Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Finasteride may improve prostate cancer treatment outcomes.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Some gonadal hormone drugs can block filovirus entry into cells.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Provenge extends prostate cancer survival by about 4 months.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.